Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment
Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...
BlackDoctor.org11d
How Chronic Myeloid Leukemia Affects Black Women Differently
Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...
How does Acute Myeloid Leukemia affect mental health and emotional well-being in patients?
The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both ...
Sacramento doctor: If not for NIH funding, I wouldn’t have survived my leukemia diagnosis | Opinion
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
Science Daily6d
Leukemia News
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...
Pulmonology Advisor7h
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in Type 2 Diabetes
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.
Q&A: Novel immunotherapy is poised to tackle multiple cancers
CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...